Hearing:
Examining HRSA’s Oversight of the 340B Drug Pricing Program
Subcommittee on Oversight and Investigations (Committee on Energy and Commerce)
Tuesday, July 18, 2017 (10:15 AM)
2322 RHOB
Washington, D.C.
Witnesses
Captain Krista M. Pedley
Director, Office of Pharmacy Affairs, Health Resources and Services Administration, U.S. Department of Health and Human Services
- Witness Statement
[PDF]
Added
07/17/2017 at 02:58 PM
- Witness Invitation
[PDF]
Added
07/12/2017 at 04:08 PM
- Questions for the Record
[PDF]
Added
09/27/2017 at 11:04 AM
- Response to Questions for the Record
[PDF]
Added
09/27/2017 at 11:04 AM
- Truth in Testimony and CV
[PDF]
Added
07/17/2017 at 02:58 PM
Debra Draper
Director, Health Care, Government Accountability Office
- Witness Statement
[PDF]
Added
07/17/2017 at 10:16 AM
- Witness Invitation
[PDF]
Added
07/12/2017 at 04:08 PM
- Truth in Testimony and CV
[PDF]
Added
07/17/2017 at 10:16 AM
Erin Bliss
Assistant Inspector General, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
- Witness Statement
[PDF]
Added
07/17/2017 at 10:16 AM
- Witness Invitation
[PDF]
Added
07/12/2017 at 04:08 PM
- Questions for the Record
[PDF]
Added
09/27/2017 at 11:04 AM
- Response to Questions for the Record
[PDF]
Added
09/27/2017 at 11:04 AM
- Truth in Testimony and CV
[PDF]
Added
07/17/2017 at 10:16 AM
Support Documents
- Hearing Notice
[PDF]
- Background Memo
[PDF]
Added
07/14/2017 at 05:23 PM
Member Statements
- Opening Statement - Oversight and Investigations Subcommittee Chairman Tim Murphy
[PDF]
Added
07/18/2017 at 10:58 AM
- Opening Statement - Full Committee Chairman Greg Walden
[PDF]
Added
07/18/2017 at 10:58 AM
Hearing Record
- Hearing Attendance
[PDF]
Added
07/19/2017 at 02:22 PM
- Preliminary Transcript
[PDF]
Added
07/25/2017 at 03:19 PM
First Published:
July 11, 2017 at 05:32 PM
Last Updated:
September 27, 2017 at 11:04 AM